LiGluR restores visual responses in rodent models of inherited blindness.

Inherited retinal degeneration results from many different mutations in either photoreceptor-specific or nonphotoreceptor-specific genes. However, nearly all mutations lead to a common blinding phenotype that initiates with rod cell death, followed by loss of cones. In most retinal degenerations, other retinal neuron cell types survive for long periods after blindness from photoreceptor loss. One strategy to restore light responsiveness to a retina rendered blind by photoreceptor degeneration is to express light-regulated ion channels or transporters in surviving retinal neurons. Recent experiments in rodents have restored light-sensitivity by expressing melanopsin or microbial opsins either broadly throughout the retina or selectively in the inner segments of surviving cones or in bipolar cells. Here, we present an approach whereby a genetically and chemically engineered light-gated ionotropic glutamate receptor (LiGluR) is expressed selectively in retinal ganglion cells (RGCs), the longest-surviving cells in retinal blinding diseases. When expressed in the RGCs of a well-established model of retinal degeneration, the rd1 mouse, LiGluR restores light sensitivity to the RGCs, reinstates light responsiveness to the primary visual cortex, and restores both the pupillary reflex and a natural light-avoidance behavior.

[1]  Jean Bennett,et al.  Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Toru Ishizuka,et al.  Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer. , 2007, Investigative ophthalmology & visual science.

[3]  A. Milam,et al.  Histopathology of the human retina in retinitis pigmentosa. , 1998, Progress in retinal and eye research.

[4]  John G. Flannery,et al.  The rd mouse story: Seventy years of research on an animal model of inherited retinal degeneration , 1994, Progress in Retinal and Eye Research.

[5]  T. Aleman,et al.  Centrosomal‐ciliary gene CEP290/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis , 2007, Human mutation.

[6]  E. Isacoff,et al.  Allosteric control of an ionotropic glutamate receptor with an optical switch , 2006, Nature chemical biology.

[7]  Jessy D. Dorn,et al.  Preliminary 6 month results from the argustm ii epiretinal prosthesis feasibility study , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[8]  E. Bamberg,et al.  Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh , 2011, Nature Neuroscience.

[9]  K. Deisseroth,et al.  Ultrafast optogenetic control , 2010, Nature Neuroscience.

[10]  C. Cepko,et al.  Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa , 2009, Nature Neuroscience.

[11]  R. Sidman,et al.  Differential effect of the rd mutation on rods and cones in the mouse retina. , 1978, Investigative ophthalmology & visual science.

[12]  Andrew A. Beharry,et al.  Spectral tuning of azobenzene photoswitches for biological applications. , 2009, Angewandte Chemie.

[13]  Ethan K. Scott,et al.  Optogenetic dissection of a behavioral module in the vertebrate spinal cord , 2009, Nature.

[14]  A. Houranieh,et al.  Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. , 2009, American journal of ophthalmology.

[15]  Alfred Stett,et al.  Subretinal electronic chips allow blind patients to read letters and combine them to words , 2010, Proceedings of the Royal Society B: Biological Sciences.

[16]  L. Maffei,et al.  The visual physiology of the wild type mouse determined with pattern VEPs , 1999, Vision Research.

[17]  Herwig Baier,et al.  Remote Control of Neuronal Activity with a Light-Gated Glutamate Receptor , 2007, Neuron.

[18]  J. Grieger,et al.  Production and characterization of adeno-associated viral vectors , 2006, Nature Protocols.

[19]  Nick Tyler,et al.  Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[20]  Krista I Kinard,et al.  Neural reprogramming in retinal degeneration. , 2007, Investigative ophthalmology & visual science.

[21]  S. Haverkamp,et al.  Morphological characterization of the retina of the CNGA3(-/-)Rho(-/-) mutant mouse lacking functional cones and rods. , 2004, Investigative ophthalmology & visual science.

[22]  Konrad Lehmann,et al.  Visual Function in Mice with Photoreceptor Degeneration and Transgenic Expression of Channelrhodopsin 2 in Ganglion Cells , 2010, The Journal of Neuroscience.

[23]  A. Dizhoor,et al.  Ectopic Expression of a Microbial-Type Rhodopsin Restores Visual Responses in Mice with Photoreceptor Degeneration , 2006, Neuron.

[24]  E. Isacoff,et al.  Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptor , 2007, Proceedings of the National Academy of Sciences.

[25]  M. Biel,et al.  Melanopsin and rod–cone photoreceptive systems account for all major accessory visual functions in mice , 2003, Nature.

[26]  Zhuo-Hua Pan,et al.  Ectopic Expression of Multiple Microbial Rhodopsins Restores ON and OFF Light Responses in Retinas with Photoreceptor Degeneration , 2009, The Journal of Neuroscience.

[27]  A. J. Roman,et al.  Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. , 2009, Human gene therapy.

[28]  C. M. Davenport,et al.  Rhodopsin mutations in autosomal dominant retinitis pigmentosa. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  James Weiland,et al.  Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis. , 2009, Progress in brain research.

[30]  B. Jones,et al.  Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration , 2008, Molecular vision.

[31]  O. Sadovski,et al.  A blue-green absorbing cross-linker for rapid photoswitching of peptide helix content. , 2006, Bioconjugate chemistry.

[32]  Karl Deisseroth,et al.  Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa , 2010, Science.

[33]  R. Masland,et al.  Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin , 2008, Proceedings of the National Academy of Sciences.

[34]  Timothy W. Dunn,et al.  Photochemical control of endogenous ion channels and cellular excitability , 2008, Nature Methods.

[35]  Edward S Boyden,et al.  Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  E. Strettoi,et al.  Age-dependent remodelling of retinal circuitry , 2009, Neurobiology of Aging.

[37]  E. Strettoi,et al.  Retinal Ganglion Cells Survive and Maintain Normal Dendritic Morphology in a Mouse Model of Inherited Photoreceptor Degeneration , 2008, The Journal of Neuroscience.

[38]  S. Stasheff,et al.  Emergence of sustained spontaneous hyperactivity and temporary preservation of OFF responses in ganglion cells of the retinal degeneration (rd1) mouse. , 2008, Journal of neurophysiology.

[39]  José-Alain Sahel,et al.  Rod-Derived Cone Viability Factor for Treating Blinding Diseases: From Clinic to Redox Signaling , 2010, Science Translational Medicine.

[40]  W. Hauswirth,et al.  Range of retinal diseases potentially treatable by AAV-vectored gene therapy. , 2004, Novartis Foundation symposium.

[41]  Douglas S Kim,et al.  Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration , 2008, Nature Neuroscience.

[42]  David J. Barker,et al.  Brief light as a practical aversive stimulus for the albino rat , 2010, Behavioural Brain Research.

[43]  T. Badea,et al.  Melanopsin cells are the principal conduits for rod–cone input to non-image-forming vision , 2008, Nature.

[44]  A. Cideciyan,et al.  Treatment possibilities for retinitis pigmentosa. , 2010, The New England journal of medicine.

[45]  P. Humphries,et al.  On the molecular genetics of retinitis pigmentosa. , 1992, Science.